Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
UCB
Market Cap: €45.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
€237.10
7D
-8.6%
1Y
38.7%